Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 591

Drug-maker AstraZeneca announced this week that the FDA is currently considering approving the needle-free option for home use. Called FluMist, the vaccine must be refrigerated and would be shipped in insulated packaging to people’s homes.

FluMist has been around for more than two decades and is approved for people ages 2 to 49 years old. It’s fallen in and out of favor over the years, including one period where a CDC advisory panel highlighted FluMist as the preferred flu vaccine for children. Later, its effectiveness was questioned, leading to a reformulation effort, STAT News reported.

AstraZeneca expects the FDA to make a decision on whether to allow home use of FluMist by Spring 2024. The convenience of home administration could increase the number of people who get a flu vaccine, said Ravi Jhaveri, MD, Chief of Infectious Diseases in the Department of Pediatrics at Northwestern University’s Feinberg School of Medicine.

Read more | >

Go to https://brilliant.org/EmergentGarden to get a 30-day free trial + the first 200 people will get 20% off their annual subscription.

Welcome to my meme complication video lolz rolf!!1! if you laugh you lose and you have to start the video over!! or if you blink or utilize any facial muscles! failing to restart or share the video will result in infinite suffering, success will result in infinite bliss.
☻/
/ ▌ copy me.
/ \

My Links.
Patreon: https://www.patreon.com/emergentgarden.
Discord: https://discord.gg/ZsrAAByEnr.
Music: https://youtube.com/@acolyte-compositions.

Sources:
Richard Dawkins ted: https://www.youtube.com/watch?v=mvJVseKdlJA
Orange Justice: https://www.youtube.com/watch?v=i0E10FASz2c.
Starling imitating camera: https://www.youtube.com/watch?v=S4IDaGo6a40
Baby imitating clapping: https://www.youtube.com/watch?v=uq1eZ8VZpSc.
Cinnamon challenge guy: https://www.youtube.com/watch?v=IqmhuYtldd0
Dawkins “It works…bitches”: https://www.youtube.com/watch?v=0OtFSDKrq88
Virus reproduction animation: https://www.youtube.com/watch?v=QHHrph7zDLw.
DNA replication animation: https://www.youtube.com/watch?v=7Hk9jct2ozY
Old bicycle: https://www.youtube.com/watch?v=p–RKyDFIAk.
Charlie bit me: https://www.youtube.com/watch?v=0EqSXDwTq6U
Vsauce fingers: https://www.youtube.com/watch?v=UMwEbsbLw3k.
Unknown Video (do not watch): https://www.youtube.com/watch?v=dQw4w9WgXcQ
The Internette: https://www.youtube.com/watch?v=Y5BZkaWZAAA
Beirut 2020 explosion: https://www.youtube.com/watch?v=LNDhIGR-83w.
Rotating Duck: https://www.youtube.com/watch?v=ggDbDRUauzo.
Free Real Estate: https://www.youtube.com/watch?v=cd4-UnU8lWY
Do I look like I know what a jpeg is: https://www.youtube.com/watch?v=QEzhxP-pdos.
Free Real Estate asmr meme: https://www.youtube.com/watch?v=CCSE6x8T0jc.
Silly red bird: https://www.youtube.com/watch?v=kUJw2eVYznw.
Silly siamangs: https://www.youtube.com/watch?v=-JUhUI_KvUI
Strong vsauce: https://www.youtube.com/shorts/crVjtJyc-r4
Jazz Frog TikTok: https://www.youtube.com/watch?v=0BWiMF8_v6M
Barry Algorithm: https://www.youtube.com/watch?v=ktAbh39aoU8
AI Pizza Ad: https://www.youtube.com/watch?v=qSewd6Iaj6I
Dawkins weird meme song: https://www.youtube.com/watch?v=2tIwYNioDL8
I could not realistically credit everything.

Timestamps.

Continue reading “Memes, Genes, and Brain Viruses” | >

The only cure for painful sickle cell disease today is a bone marrow transplant. But soon there may be a new cure that attacks the disorder at its genetic source.

On Tuesday, advisers to the Food and Drug Administration will review a gene therapy for the inherited blood disorder, which in the U.S. mostly affects Black people. Issues they will consider include whether more research is needed into possible unintended consequences of the treatment.

If approved by the FDA, it would be the first gene therapy on the U.S. market based on CRISPR, the gene editing tool that won its inventors the Nobel Prize in 2020.

Read more | >

Everdrone’s advanced service promises to reduce the average response time to under 2 minutes.

Aiming to improve emergency response services, Swedish firm Everdrone has introduced a state-of-the-art drone that combines an advanced camera system as well as customizable medical kits.

Christened E2, the multi-purpose drone aims to revolutionize emergency dispatch by providing the ability to transmit live infrared and high-definition video along with emergency medical equipment supplies. Everdrone claims that E2 will help to lower average response times under two minutes.

Read more | >

A team of researchers from TU Delft, University of Illinois, and MPI Göttingen has developed a nanoscale turbine made of DNA that can rotate in both directions depending on the salt concentration in the solution. This remarkable feat of nanotechnology could pave the way for new applications in drug delivery, biomimetics, and energy harvesting.

Natural turbines using DNA origami

A turbine is a device that converts the kinetic energy of a fluid into mechanical work. These are ubiquitous in our modern world, from wind farms to jet engines. They are also essential for life, as some biological molecules act as turbines to power cellular functions, such as the ATP synthase that produces energy for cells and the bacterial flagella that propel bacteria.

Read more | >

“For those who have lost their ability to communicate due to a variety of neurological conditions, there’s a lot of hope to preserve or regain their ability to communicate with family and friends.”

The term “brain-computer interface” (BCI) refers to a technology that creates a direct line of communication between the human brain and an outside object or computer system, opening up a wide range of possibilities for things like device control and neurological study.

Oonal/iStock.

Cortical Communication (CortiCom)

Read more | >

“High-risk mothers in many parts of rural India are usually identified in the third trimester, which is around the eighth month of pregnancy. However, by this time, it’s often too late to manage complications before labour. This can lead to fatal outcomes,” says Senthil Kumar Murugesan.

An electronics and communications engineer by profession, Senthil is trying to bridge this gap with JioVio Healthcare, an IoT-based maternal healthcare startup that provides early-risk monitoring services at home.

He first encountered the pregnancy healthcare gap when his sister was pregnant in 2016. She is a career-driven woman and would miss her antenatal appointments due to the lack of time. Also, the… More.

Madurai’s Senthil Kumar started JioVio Healthcare, which provides early risk monitoring for pregnant women in rural India. So far, he has catered to 30 lakh women in Kerala, Maharashtra, Karnataka, and Tamil Nadu.

Read more | >

In America, roughly 40 million Americans have diabetes and about 95% of them have type 2 diabetes. Type 2 diabetes occurs when the body cannot correctly process sugar and fuel cells. More specifically, the body does not produce enough insulin to break down sugar into glucose for the cells to use. In this case, treatment includes insulin shots or a pump in addition to a strict diet excluding sweets or high fat meals. Treatment limitations disrupt patient quality of life. Some researchers have been working on better detection for diabetic retinopathy with artificial intelligence (AI), but research is limited on how to better detect diabetes itself. Thus, many researchers are working to detect diabetes early on and discover better treatments.

Klick labs, located in multiple cities across the world, is trying to detect type 2 diabetes by having a patient speak into a microphone for 10 seconds. Klick labs believes this technology can better detect diabetes and help patients get treatment earlier. The study was published in Mayo Clinic Proceedings: Digital Health, which details how patients spoke for 10 seconds and combined with health data, including age, sex, height, and weight, created an AI model that discerns whether a person has type 2 diabetes or not. After further tests, scientists determined it has 89% and 86% accuracy for women and men, respectively.

In the study, Klick Labs collected voice recordings of 267 people, either non-diabetic or diabetic. The participants were asked to record a phrase into their smartphones six times a day for a total of 2-weeks. Over 18,000 recordings were taken and analyzed to distinguish 14 acoustic features that helped distinguish non-diabetic to type 2 diabetic individuals. The research highlights specific vocal variations in pitch and intensity that could lead to how the medical community screens for early-onset diabetes. A major barrier to early detection includes time, travel, and cost, which many people do not have. Voice diagnosis can help eliminate those barriers and improve detection and treatment in diabetic patients.

Read more | >

Scientists have made remarkable progress in understanding the underlying changes that make cancer grow and have applied this knowledge to develop and guide targeted treatment approaches to vastly improve outcomes for people with many cancer types. And yet treatment progress for people with brain tumors known as gliomas—including the most aggressive glioblastomas—has remained slow. One reason is that doctors lack tests that reliably predict which among many therapeutic options will work best for a given tumor.

Now an NIH-funded team has developed a miniature device with the potential to change this for the approximately 25,000 people diagnosed with brain cancers in the U.S. each year [1]. When implanted into cancerous brain tissue during surgery, the rice-sized drug-releasing device can simultaneously conduct experiments to measure a tumor’s response to more than a dozen drugs or drug combinations. What’s more, a small clinical trial reported in Science Translational Medicine offers the first evidence in people with gliomas that these devices can safely offer unprecedented insight into tumor-specific drug responses [2].

These latest findings come from a Brigham and Women’s Hospital, Boston, team led by Pierpaolo Peruzzi and Oliver Jonas. They recognized that drug-screening studies conducted in cells or tissue samples in the lab too often failed to match what happens in people with gliomas undergoing cancer treatment. Wide variation within individual brain tumors also makes it hard to predict a tumor’s likely response to various treatment options.

Read more | >